No Detail Found!

Studying the role of P-glycoprotein in resistance to Tamoxifen in human breast cancer T47D cells by immunocytochemistry.

Author(s)
Z. Motahari Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran
M. Etebary Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran
E. Azizi Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran
Abstract
In the present study, resistant subline of human breast cancer T47D cells was isolated by stepwise exposure to increasing concentrations of TAM (10-8 - 10-6 M). The subline that showed resistance to 10-6 M of TAM, named T47D/TAMR-6, was compared to the parental cells with respect to the growth characteristics, cross-resistance to Adriamycin (ADR) and P-gp expression. A significant increase in doubling time of the T47D/TAMR-6 cells was observed when compared to the parental T47D cells. This indicates a relatively slow growth rate pattern of the resistant cells. The T47D/TAMR-6 cells also showed cross-resistance to lx10-8 M concentration of ADR. Immunocytochemical analysis using monoclonal antibody (C494; Dako-Denmark) against human P-gp and LSAB2 detection kit (Dako-Denmark) revealed a significant increase in P-gp level in resistant cells when compared to parental cells. Therefore, present results indicate that P-gp can play an important role in development of resistance to TAM and cross-resistance to ADR in the human breast cancer T47D cells.
Publication Details
Page(s) 112-117
DOI DOI not available
Published Journal: International Journal of Pharmacology, Volume: 1, Issue: 2, Year: 2005

Request the full text from PASTIC

0

Citations

0

Downloads

47

Views